Equities

Lifecore Biomedical Inc

Lifecore Biomedical Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)6.74
  • Today's Change0.35 / 5.48%
  • Shares traded227.32k
  • 1 Year change-6.78%
  • Beta0.9517
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of May 26 2024202420232022
ASSETS
Cash And Short Term Investments8.46190.99
Total Receivables, Net312938
Total Inventory404136
Prepaid expenses1.444.922.05
Other current assets, total--039
Total current assets8194117
Property, plant & equipment, net151139124
Goodwill, net141414
Intangibles, net4.204.204.20
Long term investments------
Note receivable - long term------
Other long term assets3.812.922.89
Total assets254254275
LIABILITIES
Accounts payable162213
Accrued expenses191220
Notes payable/short-term debt0040
Current portion long-term debt/capital leases0.940.7098
Other current liabilities, total2.114.065.66
Total current liabilities3939177
Total long term debt1241040
Total debt125105138
Deferred income tax0.540.380.13
Minority interest------
Other liabilities, total377510
Total liabilities200218187
SHAREHOLDERS EQUITY
Common stock0.030.030.03
Additional paid-in capital178174167
Retained earnings (accumulated deficit)(167)(179)(79)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total--0(0.59)
Total equity543588
Total liabilities & shareholders' equity254254275
Total common shares outstanding313030
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.